Dissertation > Excellent graduate degree dissertation topics show

The Short and Long Term Therapeutic Observation about the Stained-release Fluorouracil for Implant for Malignant Tumors of Ovary

Author: LuJingYuan
Tutor: HanKe
School: Nanjing Medical University
Course: Clinical
Keywords: sustained-release fluorouracil for implant malignant tumors of ovary sustained-release chemotherapy
CLC: R737.31
Type: Master's thesis
Year: 2011
Downloads: 36
Quote: 0
Read: Download Dissertation

Abstract


Objective:To observe the short and long term therapeutic about the sustained-release fluorouracil(5-FU) for implant for malignant tumors of ovary.Methods:67 patients with malignant tumors of ovary,were divided into controlled group(32 cases) and treatment group(35 cases).The control group received conventional chemotherapy 2 weeks after the surgery.For the treatment group,the sustained-release 5-FU were implanted during operation,and received chemotherapy 4 weeks later. To compared the differences between the various indicators of the two groups about the short and long term therapeutic.Results: The short term therapeutic:1)The number of the treatment group of patients with tumor progression and recurrence was less than that of the control group(P<0.05); 2)39 of the 67 cases had measurable lesions left after surgery,and for the 39 cases,the therapeutic effective rate of the treatment group(21 cases) was higher than that of the control group(18 cases)(P<0.05). The long term therapeutic: 1)There was no obvious difference of the overall survival rate(1, 2, 3 years) between the treatment group and control group(P<0.05);2)1 year non-progression survival rate of the treatment group was higher than that of the control group(P<0.05), however, 2 and 3 years non-progression survival rate of the treatment group and control group did not obviously differ from each other(P>0.05); 3)There were 38 cases had measurable lesions left after surgery(1 case of censored data removed),among the 38 cases,progression-free survival of the treatment group (20 cases) longer than that of the control group (18 cases)(P<0.05). Conclusion: The sustained-release 5-FU implanted during operation might reduce the progression and recurrence rate of the patients with malignant tumors of ovary shortly after surgery, enhance the efficiency of treatment, improve the non-progression survival rate at 1 year,and prolong progression-free survival time.As the number of samples and the time of follow-up observation were very limited, the survival rate of patients over 3 years and the impact combined with other treatment needed the further observation and research.

Related Dissertations

  1. Study on Preparation of Brain-targeted BCNU Magnetic Nanospheres,R944
  2. The magnetic nanocomposite media mediated glioma slow release magnetic induction heated chemotherapy,R739.4
  3. Sustained-release chemotherapy with mitomycin fibrin gel poorly differentiated adenocarcinoma of gastrointestinal clinical research,R735
  4. The Clinical Research of Magnesium Isoglycyrrhizinate on Preventing Side Effects Caused by Intraperitoneal Chemotherapy with Sustained-release Fluorouracil for Implant in Gastric Cancer Surgery,R735.2
  5. The Recent Clinical Observation of Sustained-Release 5-Fluorouracil Used During Operation in Patients with Advanced Ovarian Elithelial Carcinoma,R737.31
  6. Effects and Mechanisms of NCPP Combined with Slow Intra-tumor Release of Drugs on Tumors in Mice,R73-3
  7. Expression and Their Significance of Apoptosis Regulatory Factors Survivin、XIAP and c-Jun、NF-κB in Epithelial Neoplasm of Ovary,R737.31
  8. Recurrent Ovarian Cancer Surgery Again with Surial Analysis of Relevant Factors,R737.31
  9. Expression and Implication of Cripto-1、 E-cadherin、 β-catenin and vimentin in Ovarian Serous Adenocarcinoma,R737.31
  10. The Recent Clinical Observation of Sustained-Release 5-Fluorouracil Used During Operation in Patients with Advanced Ovarian Elithelial Carcinoma,R737.31
  11. Construction of Recombinant Adenovirus Adv-AFPsiRNA and Study of Inhibition Effect of Adv-AFPsiRNA on Ovarian Carcinoma,R737.31
  12. Effect of Reduced Expression of PARP-1 by RNA Interference on Cisplatin Resistance and Proliferation in the Ovarian Cancer Cell Line,R737.31
  13. The Research of the Ovarian Cancer Skov3 Cells Apoptosis Induced by Brucea Javanica Oil,R737.31
  14. Recombinant Human Endostatin Combined with Radiation on Ovarian Cancer Cells H0-8910,R737.31
  15. Clinical Analysis of Virilizing Ovarian Steroid Cell Tumors: Report of 2 Cases and Review of the Literature,R737.31
  16. Expression and Signifiance of Aquaporin-5 and Aquaporin-9 in Epithelial Ovarian Tumors,R737.31
  17. Effects of DLC1 Gene Transfection on Proliferation and Migration in Human Ovarian Cancer Cell Line OVCAR-3,R737.31
  18. The Relation between Ezrin, Paxillin and ERK and the Invasion and Metastasis of Ovarian Cancer,R737.31
  19. A Study on the Relationship between β-catenin Expression and Cisplatin Resistance in Human Ovarian Cancer Cells,R737.31
  20. Mifepristone Reverse Cisplatin-resistance of Ovarian Cancer Through Up-regulating Smac and Then Promoting Apoptosis,R737.31
  21. Expression and Clinical Significance of Ub and CyclinB1 in Epithelial Ovarian Tumors,R737.31

CLC: > Medicine, health > Oncology > Genitourinary tumors > Female genital tumors > Ovarian tumors
© 2012 www.DissertationTopic.Net  Mobile